iCAD slips to net losses in Q3

iCAD, a Nashua, N.H.-based developer of image analysis and workflow technologies for the identification of cancer, has reported a net loss among its third quarter financial results, which ended Sept. 30, reflecting fewer sales.

Financial highlights for the third quarter of 2010 include the following--all comparisons are with the third quarter of 2009:

• Total revenue of $5.6 million, compared with $7.1 million, with international revenue of $776,000, compared with $371,000; and
• Net loss of $1.4 million, compared with net income of $113,000;

• Digital computer-aided detection (CAD) and MRI CAD revenue of $3.3 million, compared with $4.8 million;
• Film-based revenue of $748,000, compared with $1.3 million; and
• Service and supply revenue of $1.5 million, compared with $1 million.